Improvement in quality of life with left prefrontal transcranial magnetic stimulation in patients with pharmacoresistant major depression: Acute and six month outcomes

Brain Stimulation

Volumn 7, Issue 2, 2014, Pages 219-225

  Solvason, H B ^a   Husain, M ^b   Fitzgerald, P B ^c   Rosenquist, P ^d   Mccall, W V ^d   Kimball, J ^e   Gilmer, W ^f   Demitrack, M A ^g   Lisanby, S H ^h  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c ALFRED HOSPITAL   (Australia)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e WAKE FOREST UNIVERSITY   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g Neuronetics   (United States)

^h DUKE UNIVERSITY   (United States)

Author keywords

Antidepressant; Clinical trial; Major depression; Quality of life; TMS; Treatment resistance

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; SERTRALINE; TRAZODONE; VENLAFAXINE;

ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; COMPENSATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DRUG TREATMENT FAILURE; DSM-IV; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MENTAL COMPONENT SCORE; MENTAL HEALTH; MONOTHERAPY; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OPEN STUDY; OUTCOME ASSESSMENT; PHARMACORESISTANT MAJOR DEPRESSION; PHYSICAL COMPONENT SCORE; PREFRONTAL CORTEX; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF LIFE ENJOYMENT AND SATISFACTION QUESTIONNAIRE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SHAM PROCEDURE; SHORT COURSE THERAPY; SHORT FORM 36; SOCIAL INTERACTION; TRANSCRANIAL MAGNETIC STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION SYSTEM; TREATMENT DURATION; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DOUBLE BLIND PROCEDURE; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; RETREATMENT; SATISFACTION; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; PERSONAL SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; RETREATMENT; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84896388497     PISSN: 1935861X     EISSN: 18764754     Source Type: Journal    
DOI: 10.1016/j.brs.2013.10.008     Document Type: Article

References (49)

1. World Health Organization [Internet] Global health risks: mortality and burden of disease attributable to selected major risks; p8 2009 Available from: http://www.who.int/healthinfo/global-burden-disease/GlobalHealthRisks-report- full.pdf Cited 2013 May 8.
2. World Health Organization Fact Sheet No. 369 2012 http://www.who.int/ mediacentre/factsheets/fs369/en/.
3. E.S. Paykel, M. Weissman, B.A. Prusoff, and C.M. Tonks Dimensions of social adjustment in depressed women J Nerv Ment Dis 152 3 1971 158 172.
4. M.M. Weissman, G.L. Klerman, E.S. Paykel, B. Prusoff, and B. Hanson Treatment effects on the social adjustment of depressed patients Arch Gen Psychiatry 30 6 1974 771 778.
5. J.W. Williams Jr., C.A. Kerber, C.D. Mulrow, A. Medina, and C. Aguilar Depressive disorders in primary care: prevalence, functional disability, and identification J Gen Intern Med 10 1 1995 7 12.
6. G.I. Keitner, C.E. Ryan, and I.W. Miller Role of the family in recovery and major depression Am J Psychiatry 152 7 1995 1002 1008.
7. S.W. Geerlings, A.T.F. Beekman, J.H. Deeg, J.W.R. Twisk, and W. VanTilburg Duration and severity of depression predict mortality in older adults in the community Psychol Med 32 2002 609 618.
8. E.M. McMahon, M. Buszewicz, M. Griffin, J. Beecham, E-V. Bonin, and F. Rost et al. Chronic and recurrent depression in primary care: socio-demographic features, morbidity, and costs Int J Fam Med 2012 Article ID 316409.
9. K. Zivin, M.A. Ilgen, P.N. Pfeiffer, D.E. Welsh, J. McCarthy, and M. Valenstein et al. Early mortality and years of potential life lost among veterans affairs patients with depression Psychiatr Serv 63 8 2012 823 826.
10. K. Wells, A. Stewart, R. Hays, A. Burnam, W. Rogers, and M. Daniels et al. The functioning and well-being of patients depressed: results from the medical outcomes study JAMA 262 1989 914 919.
11. W.V. McCall, W. Cohen, B. Reboussin, and P. Lawton Effects of mood and age on quality of life in depressed inpatients J Affect Disord 55 1999 107 114.
12. D.L. Dunner, A.J. Rush, J.M. Russell, M. Burke, S. Woodard, and P. Wingard et al. Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression J Clin Psychiatry 67 5 2006 688 695.
13. D.A. Solomon, A.C. Leon, J. Endicott, T.I. Mueller, W. Coryell, and M.T. Shea et al. Psychosocial impairment and recurrence of major depression Compr Psychiatry 45 6 2004 423 430.
14. D.A. Solomon, A.C. Leon, W. Coryell, T.I. Mueller, M. Posternak, and J. Endicott et al. Predicting recovery from episodes of major depression J Affect Disord 107 1-3 2008 285 291.
15. S.R. Wisniewski, A.J. Rush, C. Bryan, R. Shelton, M.H. Trivedi, and S. Marcus et al. Comparison of quality of life measures in a depressed population J Nerv Ment Dis 195 3 2007 219 225.
16. N. Kennedy, K. Foy, R. Sherazi, M. McDonough, and P. McKeon Long-term social functioning after depression treated by psychiatrists: a review Bipolar Disord 9 1-2 2007 25 37.
17. P. Bech Social functioning: should it become an endpoint in trials of antidepressants? CNS Drugs 19 4 2005 313 324.
18. P.B. Rosenquist, G.B. Brenes, E.M. Arnold, J.K. Kimball, and V. McCall Health-related quality of life and the practice of electroconvulsive therapy J ECT 22 1 2006 18 24.
19. W.V. McCall, D. Reboussin, J. Prudic, R.F. Haskett, K. Isenberg, and M. Olfson et al. Poor health-related quality of life prior to ECT in depressed patients normalizes with sustained remission after ECT J Affect Disord 147 1-3 2013 107 111.
20. J.P. O'Reardon, H.B. Solvason, P.G. Janicak, S. Sampson, K.E. Isenberg, and Z. Nahas et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial Biol Psychiatry 62 11 2007 1208 1216.
21. M.S. George, S.H. Lisanby, D. Avery, W.M. McDonald, V. Durkalski, and M. Pavlicova et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial Arch Gen Psychiatry 67 5 2010 507 516.
22. M.A. Demitrack, and M.E. Thase Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data Psychopharmacol Bull 42 2 2009 5 38.
23. D.J.L.G. Schutter Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis Psychol Med 39 2009 65 75.
24. C.W. Slotema, J.D. Blom, H.W. Hoek, and I.E.C. Sommer Should we expand the toolbox of psychiatric treatment methods to include repetitive transcranial magnetic stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders J Clin Psychiatry 71 7 2010 873 884.
25. P.G. Janicak, Z. Nahas, S.H. Lisanby, H.B. Solvason, S.M. Sampson, and W.M. McDonald et al. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study Brain Stimul 3 4 2010 187 199.
26. D.H. Avery, K.E. Isenberg, S.M. Sampson, P.G. Janicak, S.H. Lisanby, and D.F. Maxiner et al. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial J Clin Psychiatry 69 3 2008 441 451.
27. J. Ventura, R.P. Liberman, M.F. Green, A. Shaner, and J. Mintz Training and quality assurance with the structured clinical interview for DSM-IV (SCID-I/P) Psychiatry Res 79 2 1998 163 167.
28. H.A. Sackeim The definition and meaning of treatment-resistant depression J Clin Psychiatry 16 2001 10 17.
29. J.E. Ware Jr., M.S. Bayliss, C.A. McHorney, W.H. Rogers, and A. Razcek et al. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the medical outcomes study Med Care 4 Suppl. 1995 AS264 AS279.
30. J. Endicott, J. Nee, W. Harrison, and R. Blumenthal Quality of life enjoyment and satisfaction questionnaire: a new measure Psychopharmacol Bull 29 2 1993 321 326.
31. H.C. Kraemer, and D.J. Kupfer Size of treatment effects and their importance to clinical research and practice Biol Psychiatry 59 11 2006 990 996.
32. E.H. Turner, A.M. Matthews, E.L. Linardatos, R.A. Tell, and R. Rosenthal Selective publication of antidepressant trials and its influence on apparent efficacy N Engl J Med 358 3 2008 252 260.
33. W.V. McCall, J. Prudic, M. Olfson, and H. Sackeim Health-related quality of life following ECT in a large community sample J Affective Disord 90 2-3 2006 269 274.
34. A. Schosser, A. Serretti, D. Souery, J. Mendlewicz, J. Zohar, and S. Montgomery et al. European Group for the Study of Resistant Depression (GSRD) - where have we gone so far: review of clinical and genetic findings Eur Neuropsychopharmacol 22 7 2012 Jul 453 468.
35. C. Brown, H.C. Schulberg, and M.K. Shear Phenomenology and severity of depression and comorbid lifetime anxiety disorders in primary medical care practice Anxiety 2 5 1996 210 218.
36. L.L. Judd Major depressive disorder: longitudinal symptomatic structure, relapse and recovery Acta Psychiatr Scand 104 2001 81 83.
37. J.F. Greden The burden of disease for treatment-resistant depression J Clin Psychiatry 62 Suppl. 16 2001 26 31.
38. L.L. Judd, H.S. Akiskal, P.J. Zeller, M. Paulus, A.C. Leon, and J.D. Maser et al. Psychosocial disability during the long-term course of unipolar major depressive disorder Arch Gen Psychiatry 57 4 2000 375 380.
39. S. Saarijärvi, J.K. Salminen, T. Toikka, and R. Raitasalo Health-related quality of life among patients with major depression Nord J Psychiatry 56 4 2002 261 264.
40. W.W. Ishak, K. Ha, N. Kapitansky, K. Bagot, J. Jeffry, and H. Fathy et al. The impact of psychotherapy, pharmacotherapy, and their combination on quality of life in depression Harv Rev Psychiatry 19 6 2011 277 289.
41. L.L. Judd, M.P. Paulus, K.B. Wells, and M.H. Rappaport Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population Am J Psychiatry 153 1996 1411 1417.
42. R.M. Post, P.P. Roy-Byrne, and T.W. Uhde Graphic representation of the life course of illness in patients with affective disorder Am J Psychiatry 145 7 1988 844 848.
43. R.M. Hirschfeld, G.L. Klerman, N.C. Andreasen, P.J. Clayton, and M.B. Keller Psycho-social predictors of chronicity in depressed patients Br J Psychiatry 148 1986 648 654.
44. T.K. Melartin, H.J. Rystala, U.S. Leskela, P.S. Lestela-Mielonen, T.P. Sokero, and E.T. Isometsa et al. Severity and comorbidity predict episode duration and recurrence of DSM-IV major depressive disorder J Clin Psychiatry 65 2004 810 819.
45. M.C. ten Doesschate, M.W. Koeter, L.H. Claudi, C.L. Bockting, A.H. Schene, and The DELTA Study Group Health related quality of life in recurrent depression: a comparison with a general population sample J Affect Disord 120 2010 126 132.
46. J.H. Shih, and N.K. Ebert Understanding the impact of prior depression on stress generation: examining the roles of current depressive symptoms and interpersonal behavior Br J Psychol 990 2008 413 426.
47. L. Fredman, M.M. Weissman, P.I. Leaf, and M.L. Bruce Social functioning in community residents with depression and other psychiatric disorders: results of the New Haven Epidemiologic Catchment Area Study J Affect Disord 15 1988 103 112.
48. C. Zlotnick, R. Kohn, and G. Keitner The relationship between quality of interpersonal relationships and major depressive disorder: findings from the National Comorbidity Survey J Affect Disord 59 2000 205 215.
49. W.W. Ishak, J.M. Greenberg, K. Balayan, N. Kapitansky, J. Jeffry, and H. Fathy et al. Quality of life: the ultimate outcome measure of interventions in major depressive disorder Harv Rev Psychiatry 19 5 2011 229 239